ERBB2 and breast carcinoma: In addition, suppression of v-erb-b2 erythroblastic leukemia viral oncogene homolog 2 (ERBB2) and ERBB3 by enforced expression of miR-125a or miR-125b resulted in impaired anchorage-dependent growth in breast cancer cells [48].